Published in AIDS Res Hum Retroviruses on August 10, 2002
The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials. Viruses (2010) 0.84
Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children. BMC Infect Dis (2008) 0.83
HIV-1 genetic diversity in Russia: CRF63_02A1, a new HIV type 1 genetic variant spreading in Siberia. AIDS Res Hum Retroviruses (2014) 0.82
Utility of Metagenomic Next-Generation Sequencing for Characterization of HIV and Human Pegivirus Diversity. PLoS One (2015) 0.81
Rare HIV-1 Subtype J Genomes and a New H/U/CRF02_AG Recombinant Genome Suggests an Ancient Origin of HIV-1 in Angola. AIDS Res Hum Retroviruses (2016) 0.79
CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon. J Acquir Immune Defic Syndr (2012) 0.78
Novel HIV-1 recombinant forms in antenatal cohort, Montreal, Quebec, Canada. Emerg Infect Dis (2011) 0.76
A putative HIV-1 subtype C/CRF11_cpx unique recombinant from South Africa. Springerplus (2016) 0.75
Time-scale of minor HIV-1 complex circulating recombinant forms from Central and West Africa. BMC Evol Biol (2016) 0.75
Genetic evidence for an East Asian origin of domestic dogs. Science (2002) 7.25
A detailed picture of the origin of the Australian dingo, obtained from the study of mitochondrial DNA. Proc Natl Acad Sci U S A (2004) 3.67
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis (2005) 3.52
Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One (2009) 3.40
mtDNA data indicate a single origin for dogs south of Yangtze River, less than 16,300 years ago, from numerous wolves. Mol Biol Evol (2009) 3.23
Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol (2006) 3.20
Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One (2010) 3.02
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One (2011) 2.36
A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformatics (2006) 2.25
Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One (2010) 2.04
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proc Natl Acad Sci U S A (2011) 1.93
Recombination rate and selection strength in HIV intra-patient evolution. PLoS Comput Biol (2010) 1.73
The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology (2010) 1.69
jpHMM: improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res (2009) 1.61
jpHMM at GOBICS: a web server to detect genomic recombinations in HIV-1. Nucleic Acids Res (2006) 1.58
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
Unequal evolutionary rates in the human immunodeficiency virus type 1 (HIV-1) pandemic: the evolutionary rate of HIV-1 slows down when the epidemic rate increases. J Virol (2007) 1.47
Behavioral problems and cognitive performance at 5 years of age after very preterm birth: the EPIPAGE Study. Pediatrics (2009) 1.47
Expression of water and ion transporters in tracheal aspirates from neonates with respiratory distress. Acta Paediatr (2009) 1.43
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol (2007) 1.41
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis (2010) 1.40
Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus. J Gen Virol (2009) 1.40
Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression. PLoS Comput Biol (2008) 1.39
Pyrosequencing for detection of lamivudine-resistant hepatitis B virus. J Clin Microbiol (2004) 1.39
Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J Clin Microbiol (2002) 1.30
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology (2013) 1.30
Performance of ultra-deep pyrosequencing in analysis of HIV-1 pol gene variation. PLoS One (2011) 1.29
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol (2003) 1.25
Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol (2005) 1.24
Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010. PLoS One (2012) 1.24
PCR-induced transitions are the major source of error in cleaned ultra-deep pyrosequencing data. PLoS One (2013) 1.23
Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching index. J Gen Virol (2008) 1.19
Agent-based and phylogenetic analyses reveal how HIV-1 moves between risk groups: injecting drug users sustain the heterosexual epidemic in Latvia. Epidemics (2012) 1.18
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype. J Virol (2004) 1.17
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency. J Gen Virol (2005) 1.16
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men. Antivir Ther (2006) 1.14
Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: consequences for future characterization. J Clin Microbiol (2003) 1.12
Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy. J Virol (2006) 1.10
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J Virol Methods (2003) 1.09
Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland. J Virol (2010) 1.08
CCR5 use by human immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-linked glycosylation site. J Gen Virol (2006) 1.08
Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups. AIDS Res Hum Retroviruses (2004) 1.06
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation. J Gen Virol (2005) 1.06
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge. Virology (2008) 1.04
Towards estimation of HIV-1 date of infection: a time-continuous IgG-model shows that seroconversion does not occur at the midpoint between negative and positive tests. PLoS One (2013) 1.04
Treatment of HIV infection: Swedish recommendations 2009. Scand J Infect Dis (2009) 1.03
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use. AIDS (2003) 1.00
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J Virol (2005) 0.99
A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1. J Virol Methods (2003) 0.98
Characterization of novel recombinant HIV-1 genomes using the branching index. Virology (2003) 0.97
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras. J Clin Virol (2010) 0.96
Introduction of HIV type 1 into an isolated population: molecular epidemiologic study from Greenland. AIDS Res Hum Retroviruses (2007) 0.95
Genetic characterization of the Guinea-Bissau family of Mycobacterium tuberculosis complex strains. Microbes Infect (2004) 0.95
Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: the 5' untranslated region (UTR) fails to classify subtypes. Virol J (2006) 0.95
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy. AIDS Res Hum Retroviruses (2003) 0.95
Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child. J Infect Dis (2002) 0.95
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays: results from an international collaboration on HIV-2 infection in 2006. J Clin Microbiol (2008) 0.94
A multiple-alignment based primer design algorithm for genetically highly variable DNA targets. BMC Bioinformatics (2013) 0.94
HIV-2 genetic evolution in patients with advanced disease is faster than that in matched HIV-1 patients. J Virol (2010) 0.93
Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014. Infect Dis (Lond) (2015) 0.92
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology (2012) 0.91
Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs. J Infect Dis (2013) 0.91
Norovirus strains belonging to the GII.4 genotype dominate as a cause of nosocomial outbreaks of viral gastroenteritis in Sweden 1997--2005. Arrival of new variants is associated with large nation-wide epidemics. J Clin Virol (2008) 0.91
NIDCAP and developmental care: a European perspective. Pediatrics (2013) 0.91
SCoRS--A Method Based on Stability for Feature Selection and Mapping in Neuroimaging. IEEE Trans Med Imaging (2013) 0.90
Phylogenetic analysis of the Latvian HIV-1 epidemic. AIDS Res Hum Retroviruses (2012) 0.90
The evolutionary rate dynamically tracks changes in HIV-1 epidemics: application of a simple method for optimizing the evolutionary rate in phylogenetic trees with longitudinal data. Epidemics (2009) 0.89
HIV type 1 CRF13_cpx revisited: identification of a new sequence from Cameroon and signal for subsubtype J2. AIDS Res Hum Retroviruses (2005) 0.89
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene. J Clin Microbiol (2007) 0.89
Multiple HIV-1 introductions into the Swedish intravenous drug user population. Infect Genet Evol (2008) 0.89
Antiretroviral treatment of HIV infection: Swedish recommendations 2007. Scand J Infect Dis (2007) 0.88
Transmission of the X4 phenotype of HIV-1: is there evidence against the "random transmission" hypothesis? J Infect Dis (2011) 0.88
A multiplex real-time PCR for quantification of HIV-1 DNA and the human albumin gene in CD4+ cells. APMIS (2003) 0.88
Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011. PLoS One (2013) 0.88
CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates. AIDS Res Hum Retroviruses (2002) 0.87
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-1 variants emerging during AIDS progression. Retrovirology (2008) 0.86
Science in court: the myth of HIV fingerprinting. Lancet Infect Dis (2011) 0.85
Can the further clinical development of bevirimat be justified? AIDS (2010) 0.85
Antiretroviral treatment of HIV infection: Swedish recommendations 2005. Scand J Infect Dis (2006) 0.85
Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia. J Med Virol (2010) 0.84
Breastmilk handling routines for preterm infants in Sweden: a national cross-sectional study. Breastfeed Med (2008) 0.84
Quantitative experimental determination of primer-dimer formation risk by free-solution conjugate electrophoresis. Electrophoresis (2012) 0.84
Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge. PLoS One (2011) 0.83